Order Article Reprints

Batko B, Schramm-Luc A, Skiba DS, Mikolajczyk TP, Siedlinski M. TNF-α Inhibitors Decrease Classical CD14^hiCD16− Monocyte Subsets in Highly Active, Conventional Treatment Refractory Rheumatoid Arthritis and Ankylosing Spondylitis. International Journal of Molecular Sciences. 2019; 20(2):291. https://doi.org/10.3390/ijms20020291

Batko, Bogdan, Agata Schramm-Luc, Dominik S. Skiba, Tomasz P. Mikolajczyk, and Mateusz Siedlinski. 2019. "TNF-α Inhibitors Decrease Classical CD14^hiCD16− Monocyte Subsets in Highly Active, Conventional Treatment Refractory Rheumatoid Arthritis and Ankylosing Spondylitis" International Journal of Molecular Sciences 20, no. 2: 291. https://doi.org/10.3390/ijms20020291

Batko, B., Schramm-Luc, A., Skiba, D. S., Mikolajczyk, T. P., & Siedlinski, M. (2019). TNF-α Inhibitors Decrease Classical CD14^hiCD16− Monocyte Subsets in Highly Active, Conventional Treatment Refractory Rheumatoid Arthritis and Ankylosing Spondylitis. International Journal of Molecular Sciences, 20(2), 291. https://doi.org/10.3390/ijms20020291